Kayentis Is Rolling Out Clin'form Epro For Seven Clinical Studies

Kayentis, the #1 editor of professional electronic data capture solutions for the pharmaceutical industry, is rolling out Clin’Form ePRO for seven clinical studies.

Taking an interest in the technology Digital Pen & Paper for many years, two international pharmaceutical actors have chosen Kayentis to roll out its Clin’Form ePRO solution for 7 clinical studies.

These phase III clinical studies will take place over a period between 1 month and 5 years. 1500 digital pen will be deployed in several countries around Europe and the USA; involving thousands of patients.

This success confirms the strength of the Clin’Form ePRO application, notably in terms of its ease of use, the reliability of data entered and the cost.

About Kayentis
Kayentis is the #1 publisher and operator of digital pen and smart paper solutions for the healthcare industry. These solutions, based on the Kayentis Digital Pen & Paper platform, combine the best of the physical and digital worlds: a very simple collection method (paper and pen) that offers the highest data reliability, plus all the advantages of electronic management (real‐time data access, precise timestamping, audit trail features, alerts, and transmission of relevant information to each stakeholder). Today, Kayentis solutions have been successfully deployed in 50 countries for more than 50,000 patients. Kayentis solutions are based on Anoto Digital Pen & Paper technology; Kayentis is one of the leading world partners of Anoto, and is certified Anoto Platinum Partner.

Kayentis is a member of the Pennsylvania BIO and BIO New Jersey clusters. Kayentis is an Anoto Platinum Partner, Oracle Partner and HP Solution Business Partner.

SOURCE: Kayentis